SCS a self cleaning shunt for the continuous prevention of shunt blockage in h...
SCS a self cleaning shunt for the continuous prevention of shunt blockage in hydrocephalus and NPH patients
"Microbot Medical is an award-winning start up in the medical device field that was lounched in 2010 by an expert team with extensive experience in clinical practice, mechanical engineering, electronics and business development. A...
ver más
30/11/2018
Microbot
71K€
Presupuesto del proyecto: 71K€
Líder del proyecto
MICROBOT MEDICAL LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Fecha límite participación
Sin fecha límite de participación.
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto Microbot Medical
Duración del proyecto: 5 meses
Fecha Inicio: 2018-05-31
Fecha Fin: 2018-11-30
Líder del proyecto
MICROBOT MEDICAL LTD
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
"Microbot Medical is an award-winning start up in the medical device field that was lounched in 2010 by an expert team with extensive experience in clinical practice, mechanical engineering, electronics and business development. Althouogh based in Israel, we have been building our international projection since inception, developing a first of its kind, innovative and disruptive ropotic shunt that will be able to improve the quality of life of millions of patients globally by advancing micro-robotics technologies to perform surgical procedures within the human body, and offer physicians and their patients less invasive and more precise solutions.
Hydrocephalus, also known as ""water in the brain"" is a medical condition in which there an abnormal accumulation of cerebrospinal fluid in the ventricles of the brain. An estimated 750,000 people are living with it in the US alone, with similar numbers in Europe. It causes increased intracranial pressure inside the skill and progressive enlargement of the head, convulsion, tunnel vision, and mental disability, as well as death. It is the only common form of dementia that is reversible.
Treatment is done by implanting shunts, used to drain excess fluids from patients brain, but are needed to be replaced regularly in surgery.
Microbot Medical's SCS will help lower the number of surgeries done annually around the world, estimated at over 40,000 in the US alone (once every 15 minutes) – with similar number in the EU, with a total cost of over $2B."